Issue navigation
Volume 62, Issue 9, September 2023
EDITORIALS
Impact of pregnancy on progression of preclinical autoimmune rheumatic diseases
Rheumatology, Volume 62, Issue 9, September 2023, Pages 2941–2943, https://doi.org/10.1093/rheumatology/kead099
Treat to target in RA: how strict should we be in the pursuit of remission?
Rheumatology, Volume 62, Issue 9, September 2023, Pages 2944–2945, https://doi.org/10.1093/rheumatology/kead107
Infantile Takayasu arteritis: how is it different?
Rheumatology, Volume 62, Issue 9, September 2023, Pages 2946–2947, https://doi.org/10.1093/rheumatology/kead131
Monitoring giant cell arteritis with ultrasound
Rheumatology, Volume 62, Issue 9, September 2023, Pages 2948–2950, https://doi.org/10.1093/rheumatology/kead134
SYSTEMATIC REVIEW AND META ANALYSIS
The bidirectional association between chronic musculoskeletal pain and sleep-related problems: a systematic review and meta-analysis
Rheumatology, Volume 62, Issue 9, September 2023, Pages 2951–2962, https://doi.org/10.1093/rheumatology/kead190
REVIEW
Regulatory T cells: a new therapeutic link for Sjögren syndrome?
Rheumatology, Volume 62, Issue 9, September 2023, Pages 2963–2970, https://doi.org/10.1093/rheumatology/kead070
CLINICAL SCIENCE
Impact of pregnancy on progression of preclinical autoimmune disorders: a prospective cohort study
Rheumatology, Volume 62, Issue 9, September 2023, Pages 2971–2978, https://doi.org/10.1093/rheumatology/keac637
COVID-19 admissions and mortality in patients with early inflammatory arthritis: results from a UK national cohort
Rheumatology, Volume 62, Issue 9, September 2023, Pages 2979–2988, https://doi.org/10.1093/rheumatology/kead018
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM
Rheumatology, Volume 62, Issue 9, September 2023, Pages 2989–2997, https://doi.org/10.1093/rheumatology/kead021
Five-year cardiovascular event risk in early rheumatoid arthritis patients who received treat-to-target management: a case-control study
Rheumatology, Volume 62, Issue 9, September 2023, Pages 2998–3005, https://doi.org/10.1093/rheumatology/kead039
Familial risk of seropositive rheumatoid arthritis and interaction with smoking: a population-based cohort study
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3006–3013, https://doi.org/10.1093/rheumatology/kead048
Lung function trajectory of rheumatoid arthritis–associated interstitial lung disease
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3014–3024, https://doi.org/10.1093/rheumatology/kead027
Neutrophil function following treatment of psoriatic arthritis patients with secukinumab: altered cytokine signalling but no impairment of host defence
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3025–3034, https://doi.org/10.1093/rheumatology/kead007
Determination and characterization of patient subgroups based on pain trajectories in hand osteoarthritis
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3035–3042, https://doi.org/10.1093/rheumatology/kead017
Dose–response relationships of tea and coffee consumption with gout: a prospective cohort study in the UK Biobank
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3043–3050, https://doi.org/10.1093/rheumatology/kead019
The mediating effect of fatigue in impaired quality of life in systemic lupus erythematosus: mediation analysis of the French EQUAL cohort
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3051–3058, https://doi.org/10.1093/rheumatology/kead020
Prediction of damage trajectories in systemic sclerosis using group-based trajectory modelling
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3059–3066, https://doi.org/10.1093/rheumatology/kead002
Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3067–3074, https://doi.org/10.1093/rheumatology/kead023
Quality standards for the care of people with giant cell arteritis in secondary care
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3075–3083, https://doi.org/10.1093/rheumatology/kead025
Ultrasonography in the assessment of disease activity in cranial and large-vessel giant cell arteritis: a prospective follow-up study
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3084–3094, https://doi.org/10.1093/rheumatology/kead028
Compounded sulfamethoxazole improved the prognosis of dermatomyositis patients positive with anti-melanoma differentiation-associated gene 5
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3095–3100, https://doi.org/10.1093/rheumatology/kead034
COVID-19 mRNA vaccine immunogenicity decay and breakthrough illness in adolescents and young adults with childhood-onset rheumatic diseases
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3101–3109, https://doi.org/10.1093/rheumatology/kead031
Predictors of long-term functional outcomes of juvenile idiopathic arthritis–enthesitis-related arthritis: a single centre experience
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3110–3116, https://doi.org/10.1093/rheumatology/kead032
The incidence of Kawasaki disease using hospital admissions data for England 2006–2021
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3117–3125, https://doi.org/10.1093/rheumatology/kead051
Infantile Takayasu: clinical features and long-term outcome
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3126–3132, https://doi.org/10.1093/rheumatology/keac691
A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS)
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3133–3138, https://doi.org/10.1093/rheumatology/kead012
Rapid improvement of systemic sclerosis-associated intestinal pseudo-obstruction with intravenous immunoglobulin administration
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3139–3145, https://doi.org/10.1093/rheumatology/kead093
Anti-SARS-CoV-2 vaccination in adolescent and adult patients with juvenile-onset systemic lupus erythematosus: tolerability and impact on disease activity
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3146–3150, https://doi.org/10.1093/rheumatology/kead047
BASIC SCIENCE
Rheumatoid factor recognizes specific domains of the IgG heavy chain complexed with HLA class II molecules
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3151–3155, https://doi.org/10.1093/rheumatology/kead024
The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3156–3160, https://doi.org/10.1093/rheumatology/kead052
Urine proteomics by mass spectrometry identifies proteins involved in key pathogenic pathways in patients with juvenile dermatomyositis
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3161–3168, https://doi.org/10.1093/rheumatology/kead033
RORγt inhibition ameliorates IL-23 driven experimental psoriatic arthritis by predominantly modulating γδ-T cells
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3169–3178, https://doi.org/10.1093/rheumatology/kead022
Dysbiosis of gut microbiota, a potential mediator of bile acid compositions, and prevalence of hand synovitis: a community-based study
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3179–3187, https://doi.org/10.1093/rheumatology/kead042
Detection of a rare variant in PSTPIP1 through three generations in a family with an initial diagnosis of FMF/MKD-overlapping phenotype
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3188–3196, https://doi.org/10.1093/rheumatology/kead044
Reduced digestion of circulating genomic DNA in systemic sclerosis patients with the DNASE1L3 R206C variant
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3197–3204, https://doi.org/10.1093/rheumatology/kead050
Genetics of osteonecrosis in children and adults with systemic lupus erythematosus
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3205–3212, https://doi.org/10.1093/rheumatology/kead016
Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3213–3218, https://doi.org/10.1093/rheumatology/kead152
CORRECTIONS
Correction to: Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3219–3220, https://doi.org/10.1093/rheumatology/kead247
Correction to: Vision transformer assisting rheumatologists in screening for capillaroscopy changes in systemic sclerosis: an artificial intelligence model
Rheumatology, Volume 62, Issue 9, September 2023, Page 3221, https://doi.org/10.1093/rheumatology/kead156
LETTERS TO THE EDITOR
OTHERS
Cholesteryl ester transfer protein inhibition is associated with reduced risk of Sjögren’s syndrome
Rheumatology, Volume 62, Issue 9, September 2023, Pages e258–e259, https://doi.org/10.1093/rheumatology/kead115
Factors impacting women’s advancement to positions on editorial boards of rheumatology journals
Rheumatology, Volume 62, Issue 9, September 2023, Pages e260–e262, https://doi.org/10.1093/rheumatology/kead129
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study
Rheumatology, Volume 62, Issue 9, September 2023, Pages e263–e268, https://doi.org/10.1093/rheumatology/kead149
CASE REPORTS
Venous inflammation might be one of the features of VEXAS syndrome and associated thrombosis
Rheumatology, Volume 62, Issue 9, September 2023, Pages e269–e270, https://doi.org/10.1093/rheumatology/kead168
VEXAS syndrome mimicking lupus-like disease
Rheumatology, Volume 62, Issue 9, September 2023, Pages e271–e272, https://doi.org/10.1093/rheumatology/kead076
A rare case of PLCG2-associated antibody deficiency and immune dysregulation associated with a synonymous variant in the PLCG2 gene
Rheumatology, Volume 62, Issue 9, September 2023, Pages e273–e275, https://doi.org/10.1093/rheumatology/kead085
MATTERS ARISING FROM PUBLISHED PAPERS
Comment on: Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study
Rheumatology, Volume 62, Issue 9, September 2023, Pages e276–e277, https://doi.org/10.1093/rheumatology/kead036
Comment on: Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study: reply
Rheumatology, Volume 62, Issue 9, September 2023, Pages e278–e279, https://doi.org/10.1093/rheumatology/kead037
Comment on: Detection of a rare variant in PSTPIP1 through three generations in a family with an initial diagnosis of FMF/MKD-overlapping phenotype
Rheumatology, Volume 62, Issue 9, September 2023, Pages e280–e281, https://doi.org/10.1093/rheumatology/kead102
CLINICAL VIGNETTES
Calcium pyrophosphate deposition disease mimicking spinal neuroarthropathy
Rheumatology, Volume 62, Issue 9, September 2023, Pages e282–e283, https://doi.org/10.1093/rheumatology/kead066
A rupioid rash
Rheumatology, Volume 62, Issue 9, September 2023, Pages e284–e285, https://doi.org/10.1093/rheumatology/kead073
Huge water-balloons in the belly: multiple pancreatic pseudocysts in systemic lupus erythematosus
Rheumatology, Volume 62, Issue 9, September 2023, Pages e286–e287, https://doi.org/10.1093/rheumatology/kead095
